Phase II clinical study of KW-2246 [fentanyl] in patients with cancer pain- maintenance switch study in oral morphine or oral oxycodone-treated patients
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kyowa Hakko Kogyo; Kyowa Pharmaceutical
- 21 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Oct 2010 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
- 18 Sep 2007 Status changed from recruiting to in progress.